Covid-19 vaccine: Zydus Cadila to begin phase-2 clinical trials
Drug firm Zydus Cadila on Wednesday announced that its plasmid DNA vaccine to prevent COVID-19 -- ZyCoV-D -- was found to be safe and well tolerated in the phase I clinical trial. The company will now commence phase II clinical trials from…
English
Hindi
Marathi
Punjabi
Tamil
Telugu